In contrast, insulin and oral insulin secretagogues, including sulfonylureas and glinide, markedly increased HCC risk by 1.3–2.6 fold10,12, likely by elevating serum insulin concentrations, which promote cancer cell proliferation, invasion, and metastasis13. This evidence concerns the gene INS and cancer.